Interestingly, we found that in comparison with controls, upon contact with fibronectin, RhoA-GTP levels were increased in DCs from pediatric CD patients and that the inhibition of RhoA activity prevented the morphological alterations resulting in an elongated shape observed in DCs from CD patients. This evidence concerns the gene RHOA and Cowden disease.